HON
52
5
PNW
60
4
GT
39
7
IVZ
18
3
HP
26
5
CPB
34
4
VRSK
63
9
BBY
37
2
AMT
43
2
NTAP
39
4
NWSA
69
4
WEC
75
5
PYPL
22
8
ZTS
16
6
XRAY
14
3
CHD
47
4
MAR
35
8
WU
38
8
PSX
24
5
DAL
40
4
HON
52
5
PNW
60
4
GT
39
7
IVZ
18
3
HP
26
5
CPB
34
4
VRSK
63
9
BBY
37
2
AMT
43
2
NTAP
39
4
NWSA
69
4
WEC
75
5
PYPL
22
8
ZTS
16
6
XRAY
14
3
CHD
47
4
MAR
35
8
WU
38
8
PSX
24
5
DAL
40
4
Financhill
Back

Amicus Therapeutics Stock Predictions

Mode Mobile Could be Next in Line"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
8

FOLD
Amicus Therapeutics

Last Price:
$6.47
Seasonality Move:
10.9%

7 Day Trial

ALL ACCESS PASS

$ 7

How to target income on Weekend Liquidity.

You can Watch it Here

Amicus Therapeutics Stock Forecast

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 20.7% based on the past 17 years of stock performance.
  • Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%
  • Is Amicus Therapeutics Stock Undervalued?
    The current Amicus Therapeutics [FOLD] share price is $6.48. The Score for FOLD is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Amicus Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 20.7% based on the past 17 years of stock performance.

Amicus Therapeutics Stock Rating

Sell
8
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics overpriced?

  • Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%

Amicus Therapeutics Stock Price History

Is FOLD stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com

52-Week Data

52-Week High:
12.65
52-Week Low:
6.20

Prediction Charts

Market Cap:
2B
Price in USD:
6.48
Volume:
3.8M
Beta:
1.01

Technical Analysis

SMA50:
8.85
SMA100:
9.26
SMA200:
10.06
52-Wk Change:
-42.25%

Stock Predictions

  • Is Amicus Therapeutics stock public?
    Yes, Amicus Therapeutics is a publicly traded company.
  • What is the Amicus Therapeutics stock quote today?
    The Amicus Therapeutics stock price is 6.48 USD today.
  • How to buy Amicus Therapeutics stock online?
    You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-25 8.70 8.62 8.71 8.52
Mar-26 8.63 8.52 8.67 8.40
Mar-27 8.54 8.59 8.60 8.49
Mar-28 8.61 8.43 8.62 8.36
Mar-31 8.31 8.16 8.31 7.97
Apr-1 8.18 7.95 8.24 7.90
Apr-2 7.87 7.99 8.02 7.85
Apr-3 7.83 8.00 8.06 7.72
Apr-4 7.89 7.50 7.90 7.39
Apr-7 7.30 7.15 7.54 6.99
Apr-8 7.36 6.72 7.41 6.62
Apr-9 6.53 6.89 7.06 6.20
Apr-10 6.72 6.51 6.77 6.23
Apr-11 6.50 6.48 6.78 6.33

Amicus Therapeutics Earnings

Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Amicus Therapeutics Forecast Revenue Growth

Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.27 per share, and an increase next year of $0.33 per share.

* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.